Clinical Trials Logo

Presbylarynx clinical trials

View clinical trials related to Presbylarynx.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04764604 Completed - Dysphonia Clinical Trials

Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment

Start date: December 14, 2020
Phase: N/A
Study type: Interventional

A feasibility study to identify the immediate effect on the voices of patients with voice disorders (muscle tension dysphonia, vocal fold palsy or presbylaryngis) produced by exercising with Acapella Choice as a form of semioccluded vocal tract exercise (SOVTE).

NCT ID: NCT03749863 Completed - Dysphonia Clinical Trials

Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis

Start date: February 18, 2020
Phase: N/A
Study type: Interventional

This study will investigate the safety and efficacy of four serial monthly vocal fold injections of platelet-rich plasma to treat dysphonia secondary to vocal fold atrophy, scar, and/or sulcus vocalis with glottal insufficiency

NCT ID: NCT03557775 Completed - Presbylarynx Clinical Trials

Respiratory Muscle Strength Training in Presbyphonia

Start date: June 15, 2018
Phase: N/A
Study type: Interventional

Presbyphonia is an age-related voice disorder that affects more than 10 million people in the United States. Presbyphonia is characterized by vocal fold atrophy that impairs older individuals' ability to communicate, leading to social isolation and reduced quality of life. Outcomes from current treatment approaches are often suboptimal for patients with presbyphonia as they do not sufficiently challenge the respiratory system to induce meaningful change. It is highly likely that the addition of respiratory training would result in greatly improved outcomes, such as the ability to speak loud and long enough to have a normal conversation. The purpose of this study will be to examine the effect of adding inspiratory muscle strength training (IMST) or expiratory muscle strength training (EMST) to standard of care voice therapy on respiratory and voice outcomes in patients with an age-related voice disorder. Forty-eight participants diagnosed with presbyphonia will be blocked-randomized into three intervention groups, using a 3-parallel arm design: IMST and voice exercises, EMST and voice exercises, and voice exercises during all session. Study endpoints will be the change in voice and respiratory measures after four treatment sessions compared to baseline values. Response to treatment will be analyzed to determine if there are subgroups of high- or low-responders based on baseline voice and respiratory characteristics.